An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.
Researchers found that home care workers, care agency staff and worker advocates lack understanding of AI technology, its data usage and the reasons AI systems retain their information.
Mimicry appears to be a fundamental behavior that helps people understand each other, not just when they get along, new Cornell psychology research finds.
A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.
PI-eligible faculty can request up to $115,000 in CCSS Grant Preparation Funds to support the preparation of major external funding proposals with a substantial proposal process.
A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.
Dan Kowal, associate professor of statistics and data science in the College of Agriculture and Life Sciences, has developed a new Bayesian regression analysis method that’s more flexible, accurate and easy to use.
Cornell researchers have developed a new robotic framework powered by artificial intelligence that allows robots to learn tasks by watching a single how-to video.